3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Pancreatic Neoplasms
8
Multiple Myeloma
6
Neoplasms, Plasma Cell
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Prostatic Neoplasms
3
Leukemia, Myelomonocytic, Chronic
3
Sarcoma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Inflammation
2
Frailty
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Adenocarcinoma
2
Ventilator-Induced Lung Injury
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Postoperative Complications
1
Pancreatic Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Mucositis
1
Interventions
Darbepoetin alfa
19
Epoetin Alfa
17
ACE-011
4
Cyclosporine
3
Busulfan
3
luspatercept
2
fludarabine phosphate
2
fludarabine
2
ferric carboxymaltose
2
epoetin beta
2
continuous erythropoietin receptor activator
2
Methotrexate
2
Iron-Dextran Complex
2
Filgrastim
2
Cyclophosphamide
2
vactosertib
1
thymoglobulin
1
ruxolitinib
1
roxadustat
1
peginesatide
1
pegfilgrastim
1
niraparib
1
leridistim
1
iron isomaltoside 1000
1
hematide
1
ferric gluconate
1
eltrombopag
1
angiotensin I (1-7)
1
Therapeutics
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anemia
×
Ascorbic Acid
×
Clear all
NCT06018896
2024-06-06
PTCA199-4
Fudan University
Phase 2
Recruiting
20 enrolled